ABSTRACT
INTRODUCTION
The ubiquitin-proteasome pathway (UPP) abundantly demonstrates that the proteasome is the pivotal component in cancer therapy. The UPP participates in the regulation of numerous cellular and physiological functions through specific targeted destruction of regulatory proteins. 1 Proteasomes are large multimeric protease complexes, presenting multiple targets for therapeutic intervention, that selectively and timely degrade most cellular proteins. 2 The ubiquitination of target proteins is an important mechanism for the discriminatory nature of protein degradation by proteasomes. Protein degradation by the proteasome is regulated by the ubiquitin system. The ubiquitin is a highly, evolutionarily conserved, 76-amino acid protein that serves as a tag for destruction of targeted proteins through covalent binding. On the attachment of polyubiquitin to target proteins, tagged proteins are selected for destruction by cytoplasmic organelles called proteasomes. 2 The potential of specific proteasome inhibi tors to function as anticancer agents is now of considerable interest, and has opened a new field in the cancer drug discovery. 3 It has been shown that human cancer cells are more sensitive to proteasome inhibition than normal cells, indicating that a proteasome inhibitor could be used as a novel anticancer drug. In fact, this idea has been supported by the encouraging results of the clinical trials using the proteasome inhibitors. It has been reported that some of the currently available proteasome inhibitors have undesirable side effects such as fatigue, nausea, vomiting, peripheral neuropathy, anemia, diarrhea, and constipationalong with their toxicity issues, thus cannot be used in vivo. 1 Therefore, there has been a growing interest for generating broad-spectrum proteasome inhibitors of natural origin, especially from natural products for the preventive treatment of a variety of cancers to overcome chemotherapeutic side effects. 1, 4 Influenza A (H1N1) is the subtype of influenza A virusthat is known as the most common cause of human influenza. Influenza, commonly known as 'flu' is a contagious respiratory disease induced by influenza viruses. It has been confirmed that over 220,000 hospitalizations and approximately 36,000 annual deaths are reported by influenza viruses in the United States every year. 5, 6 Current scenario on emergence of life threatening viruses has resulted in enormous attention on finding new effective class of antiviral drugs of natural origin due to the restricted efficacy of currently available vaccination program, 6, 7 and limited use of chemical synthesized antiviral drugs against influenza viruses.
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This has created an alarming demand for the development of unconventional form of measure against influenza virus. Metasequoia glyptostroboides is a deciduous coniferous tree which has been found to propagatein Eastern Asia, North America, and Europe. M. glyptostroboides has not been studied to a great extent, hence, in our ongoing efforts to find out biologically active compounds from natural products, in this study, a diterpenoid compound, taxoquinone, previously isolated from M. glyptostroboides was assessed for the first time for it anticancer and antiviral potential in terms of its ability to inhibit 20S proteasome activity and in vitro propagation of influenza virus H1N1, respectively. Previously we reported antibacterial and antioxidant potential of Metasequoia glyptostroboides derived secondary metabolites including taxoquinone. [9] [10] [11] To the best of our knowledge, no research has been reported on the proteasome inhibitory activity and antiviral potential of taxoquinone. Hence, in this study, we evaluated anticancer (human proteasome inhibition) and antiviral (influenza virus H1N1 inhibition) properties of an abietane-type diterpenoid taxoquinone.
MATERIALS AND METHODS

Chemicals and Instrument
A commercially available 20S Proteasome Assay Kit for Drug Discovery-BMLAK740 (Enzo Life Sciences, Postfach, Switzerland) was used, which provided the purified, human erythrocyte 20S proteasome, assay buffer, and fluorogenic peptide substrate SucLLVYAMC. Proteasome inhibition was determined using a fluorescent 96well microplate ELISA reader (Infinite M200, Tecan, Mannedorf, Switzerland) which measures the fluorescence of free AMC from SucLLVYAMC.
Plant Materials
The cones of M. glyptostroboides were collected from Pohang city, Korea, in November and December 2008, and identified by the morphological features and the database present in the library at the Department of Biotechnology, Daegu University, Korea. A voucher specimen was deposited in the herbarium of Department of Biotechnology, Daegu University, Korea. Dried cones of M. glyptostroboides (2 kg) were milled into powdered form and then extracted with ethyl acetate at room temperature for 12 days. The extract was evaporated under reduced pressure using a rotary evaporator (EYELA N1000, Japan). The dried ethyl acetate extract (7 g) was subjected to column chromatography over silica gel (mesh 230400 mesh, Merck, Darmstadt, Germany) and was eluted with hexane-ethyl acetatemethanol solvent system to give 20 fractions. Of the fractions obtained, fraction12 was further purified by preparative TLC over silica gel GF 254 using hexane-ethyl acetate (1:2) as a mobile phase to give one compound (152 mg) which on the basis of spectral data analysis was characterized as taxoquinone. The proteasome inhibition assay was done as follows; 3% sodium dodecyl sulfate was added to assay buffer to activate the 20S proteasome's chymotrypsinlike activity. 4 The assay buffer was added to the blank and sample plate, and a diluted solution of positive control was added to the inhibitor wells. The enriched proteasome fraction was diluted to a final assay concentration of 10 μg/mL using assay buffer. This diluted fraction was then added to each well, and then, the plate was preincubated for 10 min at 37 o C to allow the inhibitor and enzyme to interact. The enzymatic reaction was started by adding SucLLVYAMC substrate to a final concentration of 75 μM. The chymotrypsinlike enzymatic activity of the proteasome was determined by measuring the generation of free AMC using a fluorescent ELISA plate reader, capable of excitation at a wavelength of 360 nm and detection of emitted light at 460 nm. Epoxomicin was used as the positive control, EID 50 /0.1 mL using 50% end point dilution assay as described by Reed and Muench. 13 
Antiviral Potential of Taxoquinone (CytopathicReduction Assay)
For assessing the cytopathic reduction effect of the taxoquinone, MDCK cell line was cultured in a 96 well microplate using Eagle's minimal medium (MEM) with 10% (v⁄v) fetal bovine serum (FBS), 1% (v⁄v) 100U/mol penicillin and 100 µg/mL streptomycin solution for 24-36 h at 37ºC, with 5% CO 2 in a cell-culture incubator. MDCK cells were seededonto a 96well culture plate at the concentration of 2 × 10 4 cells per well. Sugiol was serially diluted twofold with 2% FBS DMEM solution. IFV H 1 N 1 was treated with two-fold diluted samples of taxoquinone at 37 o C, and 5% CO 2 in cell culture incubator for 1 h. This mixture was inoculated into MDCK cells and incubated in DMEM solution with 2% FBS at 37ºC in a humidified chamber with 5% CO 2 for 72 h using a multi-pipette. The plates were observed for cytopathic effect (CPE) after 72 h, and the reduction of CPE was regarded as the presence of antiviral activity.
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Statistical Analysis
The data were expressed as the mean ± SD of three independent experiments and analyzed using oneway analysis of variance and Student's ttest. p values of <0.05 were considered to be statistically significant.
RESULTS AND DISCUSSION
Taxoquinone
The ethyl acetate cone extract of M. glyptostroboides after column chromatography over silica gel yielded a pure compound which was obtained as orange needles with a specific melting point (mp 212214 o C). The which is a rapid, potent and irreversible inhibitor of the 20S proteasome chymotrypsinlike activity.
Culture of MDCK Cell Line
Madin-Darby canine kidney (MDCK) cells (KTCC® AC30015) used in this study were grown in highglucose Dulbecco'smodified Eagle's medium (DMEM) (Sigma Aldrich, St. Louis, MO) supplemented with 10% heatinactivated standard fetal bovine serum (FBS) (HyClone, Logan, UT) and 1% (v⁄v) 100 U/mol penicillin and 100 µg/mL streptomycin solution at room temperature (23 ± 1°C) undernormal atmospheric conditions. Cells were sub-cultured at a 1:3 ratio every 34 days. Briefly, DMEM medium from TC75 cm 2 flasks was collected and centrifuged at 1,500 rpm for 5 min. Meanwhile, 5mL/flask of a trypsinversine solution (10 mL 10x Trypsin(SigmaAldrich, St. Louis, MO) in 90 mL presterilizedversine (EDTA) solution was added and incubated for 1 min to detach thecell monolayer. 12 Following cell detachment, cleaned medium was added back into the flasks to neutralize thetrypsin activity. The contents of the flasks were then removed and centrifuged at 1,500 rpm for 5 min. Following centrifugation, supernatant was removed and new growth medium was used to re-suspend the cells. Cells, split 1:3, were placed back into flasks and to talmedia volume was brought up to 2022 mL/flask. Flasks were then placed back into their respective incubators and monitored daily.
Virus Culture and Harvesting of H1N1 Virus from Embryonated Egg
Highly pathogenic influenza virus (IFV) H1N1 (A/Korea/ 01/2009) was obtained from Korea Centers for Disease Control and Prevention, Korea. The IFV H1N1 was grown in the allantoic cavity of 11 days old chicken embryo for 3 days. In brief, specificpathogenfree (SPF) chicken eggs were cleaned by 70% (v/v) ethanol and incubated for embrocation in a rotating and static egg incubator for at 35ºC with humidified environment for 11 days. After that, 100 µL of IFV H1N1 was inoculated in the allantoic cavity by using 1 mL syringe with 27-gauge, 1-inch or 1.5-inch hypodermic or blunt-end needle and the punched holes were sealed with wax followed by incubation at 35°C in a humidified static incubator for 2-3 days. At the completion of incubation period, eggs were prepared for fluid collection by placing them on ice (at 4°C) overnight. Then, 3 mL syringe with a 21-gauge, 1-inch hypodermic needle was used to collect the harvested allantoic fluid. Allantoic fluid was stored at 80°C as a stock solution of the IFV H1N1 A virus. Virus titers in the allantoic fluid stock solution were determined as anembryo infectiondose and 183.7 in the 13 C NMR data strongly suggested that this compound should be an abietane diterpenoid. On the basis of the interpretation of HMQC and HMBC data, this compound was proposed to be taxoquinone. 15 By comparison of the multiplicity of H7 and the chemical shifts both in the 1 
H and
13
C NMR data, the structure of this compound (Figure 1 ) was determined to be taxoquinone.
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Inhibition of 20S Human Proteasome
Nowadays attention has been focused on finding natural inhibitors of proteasome due to their potent anticancer potential. 1, 17 Particularly, bortezomib, NPI0052, and lactacystin, have been considered specific protease inhibitors for the treatment of variety of cancers, due to their direct growth-inhibitory and apoptotic effects on cancer cells as also approved by USFDA.
1 In addition, several evidences from pre-clinical and clinical trials have supported the hypothesis that targeting the proteasome inhibition could be a promising strategy for the treatment of variety of cancers. Since the discovery of first generation of proteasome inhibitors, including bortezomib and lactacystin, a largerange of otherchemically synthesized proteasome inhibitors were developed and isolated from natural resources for the treatment of multiple myeloma cancer cells. 1 Previously relationship between proteasomal chymotrypsin-like activity and tumor growth demonstrated potent efficacy of withaferin A (steroidal lactone), an effective inhibitor of angiogenesis, resulting in tumor growth inhibition associated with inhibition of tumor tissue proteasomal chymotrypsin-like activity. 1 To investigate the 20S proteasome inhibitory activity of taxoquinone, commercially available purified human erythrocyte 20S proteasome was used in this study. SucLeuLeuValTyr linked to fluorogenic aminomethylcou marin (SucLLVYAMC) was used as a substrate to determine the chymotrypsinlike activity of 20S proteasome. The inhibitory activity was determined by measuring the generation of free AMC using a fluorescence plate reader after adding SucLLVYAMC to the incubated mixtureof compoundand 20S proteasome. The inhibitory activity of taxoquinone against 20S proteasome has been presented in Figure 2 . Interestingly, taxoquinone inhibited the activity of 20S proteasome in a dose-dependent manner with IC 50 values of 8.2 ± 2.4 µg/µL. A known proteasome inhibitor, epoxomicin (IC 50 5.1 ± 1.4 μg/μL), was employed as a positive control in this assay. Various proteins involved in the processes of carcinogenesis and cancer survival have been identified as targets of the proteasome, including cyclins A, B, D and E, as well as tumor suppressor protein p53, pro-apoptotic protein Bax, cyclindependent kinase inhibitor (CKI) p27, and the inhibitor of NFκB, and IκBα.
1 Specific inhibition of chymotrypsinlike activity is an efficient biological effect for the induction of neurite outgrowth, and apoptosis in cancer cells. To reduce the recovery period and potentially promote the efficacy of chemotherapeutics, it is critical to eliminate noxious substances in the treatment of cancer. Hence, cancerpreventive and anticancer effects of natural products are widely supported by the results obtained from epidemiological, cell culture, and animal studies, and a number of microbial metabolites and plant polyphenols have been implicated as natural proteasome inhibitors. 1 The ubiquitin-proteasome proteolytic system plays an important role in selective protein degradation and regulates cellular events, including cell-cycle progression, apoptosis, and inflammation.
18 Since proteasomes interact primarily with endogenous proteins, inhibition of the proteasome may block the signaling action of the transcription factor NFκB, thus inhibit the completion of the cell cycle and the mitotic proliferation of cancerous cells, leading to cell death by apoptosis, and inhibition of angiogenesis and metastasis. Previously 20S proteasome inhibitory activities of various natural products including, coumarins, terpenes, flavonoids, phenols and saponins have been reported by others. 4, 17, 19 In addition, biological structure activity relationship also gives conformational evidences that presence of carbonyl group in taxoquinonemay influence the inhibitory activity against 20S proteasome.
20 It has been reported that carbonyl carbon in natural compounds is electrophilic. Electrophilic functional groups of inhibitors are susceptible to be attacked by the proteolytically active Thr 1O γ that is nucleophilic, which might be responsible for the observed inhibitory effect of taxoquinone on 20S proteasome.
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Moreover, a number of diterpenoid compounds exhibit anticancer and antitumor effects or induce apoptosis, associated with cell cycle arrest at the G(2)/M phase, modulation of cyclin expression and by downregulating the proto-oncogene c-myc, as well asinhibit bcl-x(L) expression, which together cause DNA fragmentation and nuclear chromatin condensation. It has been reported that a diterpenoid induces apoptosis in human leukemia cells through a caspase-8-dependent pathway. 21 Treatment of human leukemia cancer cells by kaurene type diterpenoid led to a time-dependent cleavage of Bid, a substrate of caspsase-8, as well as to the proteolytic processing of procaspase-8, indicating that kaurene type diterpenoid compounds induce apoptosis through caspase-8-dependent pathway. 21 In addition, over expression of drug resistance factor Bcl-2, which is frequently over expressed in many tumors, failed to confer resistant to diterpenoid-induced cytotoxicity. 21 Similarly, other researchers have also reported antitumor and/or anticancer efficacy of various terpenoid compounds in various cancer cell lines. 1, 22 Based on these findings, it is speculated that specific inhibition of chymotrypsinlike activity is an efficient biological effect for the induction of neurite outgrowth, and apoptosis in cancer cells, 1 suggesting a positive correlation of taxoquinone as an effective anticancer molecule on proteasome inhibition.
Inhibition of H1N1 Influenza Virus
Nowadays human population has been markedly affected by the highly contagious influenza viruses worldwide. In general, severity of influenza virus infection has been commonly observed in the mucous membranes of the upper respiratory tract, however, it may also cause deleterious effect on human lungs, 23 leading to secondary infection in susceptible individuals such as infants and the elderly. 24 Influenza viruses are classified into type A, B and C, with type A appearing to be the most notorious candidate. 25 The epidemiology of influenza virus type A and B is distinctive due to their seasonality and antigenic variation. The gradual antigenic drift of influenza virus type A and B coupled with occasional antigenic shift make it difficult to control the infection.
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Current therapeutic agents against influenza viruses include amantadine and rimantadine, however, severe side effects and development of resistance have limited their practical applications, generating a huge need to develop new, effective and broad-spectrum antiviral agents. To confirm the biomedicinal potential, taxoquinone was assessed for it santiviral efficacy against influenza virus H1N1on MDCK cells. It was observed that H1N1 induced cytopathic effect (CPE) in MDCK cells when used alone ( Figure 3A) . However, no CPE was observed in control MDCK cells ( Figure 3B ). Microscopic observations confirmed that MDCK cells treated with H1N1 and taxoquinone showed similar morphology as did by the control MDCK cells (without any treatment) even after 72 h of the viral injection ( Figure 3C ). These results confirmed that taxoquinone isolated from M. glyptostroboides could be a potent antiviral candidate able to control CPE in MDCK cells caused by influenza virus H1N1. Natural products such as terpenes or terpenoidshave shown great potential of therapeutic efficacy in terms of their potent antiviral efficacy against various types of viruses. As reported previously, sterols and terpenoids such as ganoderone A, lucialdehyde B, and ergosta-7,22-dien-3â-ol also exhibited profound antiviral effect against herpes simplex virus.
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A sesquiter penoid, gossypol isolated from the cotton seeds has been found to exhibit antiviral activity and inhibited the growth of influenza virus in vitro. 27 In addition, glycyrrhizin, a terpenoid isolated from higher plantsexhibited significant antiviral activity against influenza virus in vitro. 28 Antiviral efficacy of polyphenolic compounds has also been reviewedpreviously, 29 and it was found that compounds of terpene nature have potential efficacy to inhibit in vitro growth of influenza virus H1N1. From these findings, it can beestimated that antiviral activity of polyphenolic compounds might be associated with the inhibition of hemagglutination activity(HA), because HAs of different subtypes usually express distinct antigenic signature in the globular head domain, 29 suggesting this activity might be occurred by the nonspecific masking of HA heads. These findings demonstrated that taxoquinone, being a terpene family member, may also inhibit in vitro growth of H1N1 influenza virus via similar mechanism. In addition, inhibition of viral protein maturation via blocking of signaling pathways may also be proposed as an antiviral action of taxoquinone as also observed previously.
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CONCLUSION
Therapeutic efficacy of terpenoid compounds as natural inhibitors of human proteasome and influenza virus may provide a viable modality on the crucial role of proteasome in the pathological state of cancer and contagious respiratory H1N1 influenza virus for the preventive treatment of cancer and viral disorders. This could be considered the first report on the inhibitory effect of taxoquinone on 20S human proteasome and influenza virus H1N1, and the results of the study indicate that taxoquinone could be a promising anticancer and antiviral agent, as confirmed by its chymotrypsinlikeinhibitory activity on human 20S proteasome and in vitro growth inhibition of influenza virus H1N1 on MDCK cell line. This study reinforces the suggestions that using an innocuous natural productsas monotherapy or in synergismmay boost the effectiveness of current chemotherapeutics, leading to the development of a new and safer classes of potential anticancer and antiviral drugs.
